CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Actigraphy for sleep/wake assessment (coverage criteria)

Defines Blue Cross Blue Shield - Rhode Island coverage stance on use of actigraphy to record and analyze body movement for evaluation of sleep disorders and related indications for both Medicare and commercial products.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyActigraphy for sleep/wake assessment (coverage criteria)

Policy CodePolicy N/A

Change TypeNo material change

Effective Date

Next Review Date

Key ActionDo not separately report actigraphy when it is used as a component of portable sleep monitoring.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

95803Not covered CPT

72h–14dRecording duration

2015–2020Published dates

510(k)FDA clearance

Coverage criteria for actigraphy

Coverage determination

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyActigraphy for sleep/wake assessment (coverage criteria)

Policy CodePolicy N/A

Change TypeNo material change

Effective Date

Next Review Date

Key ActionDo not separately report actigraphy when it is used as a component of portable sleep monitoring.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Primary coverage rule: Actigraphy when used as the sole technique to record and analyze body movement (including to evaluate sleep disorders) is considered not covered / not medically necessary.

Applies to BlueCHiP for Medicare and Commercial Products as stated.

Component use: Actigraphy used as a component of portable sleep monitoring is not separately reportable; component use is not excluded from coverage but cannot be billed separately.

See statements that component use should not be separately reported.

Evidence and regulatory context: Although numerous actigraphy devices have received FDA 510(k) clearance, the evidence does not demonstrate clinical utility over alternatives (e.g., sleep diary) and actigraphy is not considered as beneficial as established alternatives; therefore it is considered investigational and not medically necessary for use as the sole technique.

Regulatory clearance does not imply coverage; clinical validity concerns cited.

Actigraphy when used as the sole technique to record and analyze body movement — including for the evaluation of sleep disorders — is not covered / not medically necessary. This applies across product lines as stated for BlueCHiP for Medicare and Commercial Products. When actigraphy is incorporated as a component of portable sleep monitoring, that component use is not excluded from coverage but should not be separately reported.

For Commercial products, actigraphy used as the sole technique to record and analyze body movement to evaluate sleep disorders is considered not medically necessary. CPT code 95803 (Actigraphy testing, recording, analysis, interpretation and report) is listed as not medically necessary/not covered; when billed, verify group/contract benefits and Evidence of Coverage for applicable coverage determinations.

Coding and billing guidance

Not medically necessary / Not covered CPT CodesCPTNot Covered

95803

Actigraphy testing, recording, analysis, interpretation and report (minimum of 72 hours to 14 consecutive days of recording)

Recording duration for CPT 95803 — minimum/typical duration referenced

CPT code95803

Procedure descriptionActigraphy testing, recording, analysis, interpretation and report

Recording duration (per CPT 95803)Minimum of 72 hours to 14 consecutive days

Provider actions, billing rules, and denial triggers

Prior Authorization

Prior authorization

Not applicable

Note

Provider action

Actigraphy is considered not covered when used as the sole technique to record and analyze body movement, including but not limited to its use to evaluate sleep disorders. This does not include the use of actigraphy as a component of portable sleep monitoring.

When used as a component of portable sleep monitoring, actigraphy should not be separately reported.

Billing Rule

Billing rule

When used as a component of portable sleep monitoring, actigraphy should not be separately reported.

Denial Risk

Denial triggers

Actigraphy used as the sole technique to record and analyze body movement (including for evaluation of sleep disorders) is considered not medically necessary / not covered. The following code is not medically necessary/not covered: 95803 — Actigraphy testing, recording, analysis, interpretation and report (minimum of 72 hours to 14 consecutive days of recording). Benefits may vary by group/contract; refer to Evidence of Coverage or Subscriber Agreement.

Denial trigger: Use of actigraphy as the sole diagnostic technique.
Not medically necessary / not covered code: 95803.

Background and context

Actigraphy refers to the assessment of activity patterns using devices typically placed on the wrist or ankle that record body movement; algorithms interpret those movements to estimate periods of sleep and wake. Devices may be used to assess circadian rhythm disorders, insomnia, hypersomnolence, and activity levels, but actigraphy has known limitations compared with polysomnography, particularly in distinguishing sleep from wake in individuals with disturbed sleep.

Numerous actigraphy devices have received U.S. Food and Drug Administration (FDA) clearance for marketing through the 510(k) process, and recordings commonly span multiple days. Per coding guidance, actigraphy testing described by CPT code 95803 specifies a recording duration of a minimum of 72 hours to 14 consecutive days.

Because actigraphy provides an indirect measure of sleep through movement, its clinical utility varies by indication and it is not accepted as a standalone diagnostic substitute for polysomnography in the evaluation of sleep disorders; policy reflects that standalone use is not covered while component use within portable monitoring is allowable but should not be billed separately.

Definitions

Actigraphy definition — device description and interpretation

DefinitionAssessment of activity patterns by devices typically placed on the wrist or ankle that record body movement, interpreted by computer algorithms as periods of sleep (absence of activity) and wake (activity).

Typical placementWrist or ankle

InterpretationRecorded movement data are analyzed by algorithms to infer sleep/wake cycles; used to assess circadian rhythm disorders and other sleep-wake disturbances.

LimitationsComparisons with polysomnography show limitations in distinguishing sleep from wake in disturbed sleep and in reliably measuring sleep efficiency.